MedPath

Digital Technologies for Stroke Prevention Trial (DIGITS Trial)

Not Applicable
Not yet recruiting
Conditions
stroke secondary prevention
Stroke - Ischaemic
Registration Number
ACTRN12624001168549
Lead Sponsor
Auckland University of Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not yet recruiting
Sex
All
Target Recruitment
360
Inclusion Criteria
  1. People aged 35-85 years old diagnosed with TIA or minor stroke (including recurrent events) with ambulant modified Rankin Scale (mRS) score 0-3 at discharge or independent in activities of daily living in the past 90 days.2. Admitted to one of the two Auckland based hospitals or identified via outpatient clinics or primary care for minor stroke or TIA.3. Can converse in English.4. Systolic blood pressure greater than or equal to 130 mmHg, or greater than or equal to 120 mmHg if on blood pressure medications. 5. Has access to a Smartphone or Smart Device (iPad, Tablet).6. Provides written informed consent.
Exclusion Criteria
  1. History of major stroke, subarachnoid haemorrhage or major myocardial infarction (verified through Clinical Portal medical records)2. Life-threatening conditions with a life-expectancy less than 5 years.3. Current (in the past year) significant clinical depression/anxiety measured by the Hospital Anxiety and Depression questionnaire (HADS) at a level greater than or equal to 14 in either or both the depression and anxiety domains (either in clinical records or at screening) OR psychiatric conditions (based on medical records).4. History (past year) of alcohol or drug/ substance abuse.5. Dependent on others (living in a rest-home/care facility).6. Unable to have telephone assessments due to hearing difficulties.7. Significant cognitive impairment or pre-existing diagnosis of dementia, e.g., at screening (T-MoCA less than 15). People with less than 12 years education and those for whom English is not the first language will score an additional point for each circumstance.8. Participation in another current RCT or major research study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in systolic blood pressure[Automated digital sphygmomanometer At baseline and 6-months post randomisation (plus 4 weeks or minus 2 weeks)]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath